BCIQ Profiles

Company Profile Report
0524 QTs
BioCentury & Getty Images


May 24 Quick Takes: Neurology play Eliem raises $60M series B; plus Xeris-Strongbridge, CARsgen, Janssen, Abivax and Takeda

May 24, 2021 | 11:32 PM GMT

Two months after emerging from stealth with $80 million, Eliem Therapeutics Inc. closed a $60 million series B

Read the full 454 word article

How to gain access

Continue reading with a
two-week free trial.